BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23505010)

  • 1. Trisomy 21 and facial developmental instability.
    Starbuck JM; Cole TM; Reeves RH; Richtsmeier JT
    Am J Phys Anthropol; 2013 May; 151(1):49-57. PubMed ID: 23505010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological integration of soft-tissue facial morphology in Down Syndrome and siblings.
    Starbuck J; Reeves RH; Richtsmeier J
    Am J Phys Anthropol; 2011 Dec; 146(4):560-8. PubMed ID: 21996933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of trisomy 21 on facial form and variability.
    Starbuck JM; Cole TM; Reeves RH; Richtsmeier JT
    Am J Med Genet A; 2017 Nov; 173(11):2861-2872. PubMed ID: 28941128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microstructure of trabecular bone in a mouse model for Down syndrome.
    Parsons T; Ryan TM; Reeves RH; Richtsmeier JT
    Anat Rec (Hoboken); 2007 Apr; 290(4):414-21. PubMed ID: 17514765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes.
    Redhead Y; Gibbins D; Lana-Elola E; Watson-Scales S; Dobson L; Krause M; Liu KJ; Fisher EMC; Green JBA; Tybulewicz VLJ
    Development; 2023 Apr; 150(8):. PubMed ID: 37102702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
    Pritchard MA; Kola I
    J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Variations in the Facial Soft Tissues of Individuals With Down Syndrome: Sudan Versus Italy.
    Sforza C; Dolci C; Dellavia C; Gibelli DM; Tartaglia GM; Elamin F
    Cleft Palate Craniofac J; 2015 Sep; 52(5):588-96. PubMed ID: 25275539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuating dental asymmetry: a measure of developmental instability in Down syndrome.
    Barden HS
    Am J Phys Anthropol; 1980 Feb; 52(2):169-73. PubMed ID: 6445164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital facial dysmorphology for genetic screening: Hierarchical constrained local model using ICA.
    Zhao Q; Okada K; Rosenbaum K; Kehoe L; Zand DJ; Sze R; Summar M; Linguraru MG
    Med Image Anal; 2014 Jul; 18(5):699-710. PubMed ID: 24835178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome.
    Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH
    Am J Med Genet; 2002 Feb; 107(4):317-24. PubMed ID: 11840489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The facial morphology in Down syndrome: A 3D comparison of patients with and without obstructive sleep apnea.
    Jayaratne YSN; Elsharkawi I; Macklin EA; Voelz L; Weintraub G; Rosen D; Skotko BG
    Am J Med Genet A; 2017 Nov; 173(11):3013-3021. PubMed ID: 28815893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
    Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
    Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.
    Blazek JD; Gaddy A; Meyer R; Roper RJ; Li J
    Bone; 2011 Feb; 48(2):275-80. PubMed ID: 20870049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial profile and additional features in fetuses with trisomy 21.
    Radhakrishnan P; Nayak SS; Shukla A; Girisha KM
    Clin Dysmorphol; 2018 Oct; 27(4):126-129. PubMed ID: 29985174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Face-brain asymmetry in autism spectrum disorders.
    Hammond P; Forster-Gibson C; Chudley AE; Allanson JE; Hutton TJ; Farrell SA; McKenzie J; Holden JJ; Lewis ME
    Mol Psychiatry; 2008 Jun; 13(6):614-23. PubMed ID: 18317467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down syndrome phenotypes: the consequences of chromosomal imbalance.
    Korenberg JR; Chen XN; Schipper R; Sun Z; Gonsky R; Gerwehr S; Carpenter N; Daumer C; Dignan P; Disteche C
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4997-5001. PubMed ID: 8197171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.